Empirical Asset Management, LLC Cassava Sciences Inc Transaction History
Empirical Asset Management, LLC
- $791 Million
- Q3 2024
A detailed history of Empirical Asset Management, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Empirical Asset Management, LLC holds 10,000 shares of SAVA stock, worth $264,800. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$264,800
Previous $123,000
139.02%
% of portfolio
0.04%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
207Shares Held
14MCall Options Held
2.98MPut Options Held
6.57M-
Black Rock Inc. New York, NY3.22MShares$85.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$66.8 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$30.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$26.7 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO580KShares$15.4 Million7.83% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $1.06B
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...